您现在的位置: 首页> 研究主题> 羟丁酸钠

羟丁酸钠

羟丁酸钠的相关文献在1989年到2022年内共计175篇,主要集中在药学、外科学、儿科学 等领域,其中期刊论文174篇、会议论文1篇、专利文献20239篇;相关期刊101种,包括河南外科学杂志、临床麻醉学杂志、中国麻醉与镇痛等; 相关会议1种,包括山东省麻醉学会第九次学术会议等;羟丁酸钠的相关文献由405位作者贡献,包括戴体俊、张铁铮、谷淑玲等。

羟丁酸钠—发文量

期刊论文>

论文:174 占比:0.85%

会议论文>

论文:1 占比:0.00%

专利文献>

论文:20239 占比:99.14%

总计:20414篇

羟丁酸钠—发文趋势图

羟丁酸钠

-研究学者

  • 戴体俊
  • 张铁铮
  • 谷淑玲
  • 张明阳
  • 曾因明
  • 王凤学
  • 马正良
  • 张晶
  • 张研
  • 陈莺

羟丁酸钠

-相关会议

  • 期刊论文
  • 会议论文
  • 专利文献

搜索

排序:

年份

    • 赵安琪; 赵平
    • 摘要: 羟丁酸钠曾广泛用于临床镇静和麻醉,后因其麻醉作用单一而逐渐减少使用。近年来,羟丁酸钠被证实可以治疗发作性睡病,同时对改善阿尔茨海默病和帕金森病等疾病的睡眠障碍症状有效。本文对羟丁酸钠改善睡眠障碍作用的临床应用现况及相关研究进展进行综述,并探讨了其潜在的临床应用价值。
    • 夏训明(编译)
    • 摘要: 美国FDA于2021年8月12日批准Jazz制药公司(Jazz Pharmaceuticals plc.)的Xywav口服液用于成人治疗特发性过度睡眠症(Idiopathic hypersomnia,IH)。Xywav为一种复方药物,其有效成分为4种羟丁酸盐,包括羟丁酸钙、羟丁酸镁、羟丁酸钾和羟丁酸钠(calcium,magnesium,potassium,and sodium oxybates)。
    • 徐清霖; 楼国东; 王甜甜; 张力三
    • 摘要: 发作性睡病是致残性白天睡眠增多的最常见原因之一,其治疗旨在减少白天睡眠增多和猝倒,改善夜间睡眠紊乱、睡眠瘫痪及与睡眠有关的幻觉.2019年,组胺H3受体拮抗剂替洛利生(Pitolisant)和多巴胺及去甲肾上腺素再摄取抑制剂索利氨酯(Solriamfetol)分别在欧盟和美国上市,前者具有促醒和抗猝倒作用,后者也有促醒作用,且戒断症状和滥用的发生率更低.目前,控释型羟丁酸钠(FT218)、低钠型羟丁酸盐(JZP-258)、选择性去甲肾上腺素再摄取抑制剂(瑞波西汀,又称AXS-12)以及莫达非尼联合氟卡尼制剂(THN102)等药物仍在开发和测试中,均可作为治疗发作性睡病相关白天睡眠增多和猝倒的潜在药物.本文重点介绍这些最近研发的发作性睡病治疗药物.
    • 白芙蓉; 吴畏
    • 摘要: 目的:探讨羟丁酸钠通过Rho/Rho激酶信号通路对脑缺血再灌注大鼠脑损伤的作用.方法:通过右侧血管内大脑中动脉闭塞(MCAO)构建局灶性脑缺血再灌注模型.造模前40 min腹腔给予50、100、200 mg/kg羟丁酸钠,1次/d,连续灌胃1周.尼莫地平组腹腔每天给予0.7 mg/kg尼莫地平,水仙环素组和给药高剂量+水仙环素组以相同方式每天给予10 mg/kg水仙环素.对照组和模型组大鼠注射等体积生理盐水.开场行为检测自发活动情况,T迷宫实验检测学习记忆能力,检测脑组织含水量,HE染色观察脑损伤,TUNEL染色检测脑细胞凋亡情况,qRT-PCR检查RhoA、Rho-kinaseα 和Rho-kinaseβmRNA表达水平,Western blot检测cleaved caspase-3、Bax、Bcl-2、RhoA、Rho-kinaseα和Rho-kinaseβ 蛋白表达水平.结果:与模型组相比,给药高剂量组大鼠10 min内爬行经过的格子数目明显减少(P<0.01),选择正确次数明显增多(P<0.01),脑组织含水量明显减少(P<0.01),脑组织细胞凋亡率明显减少(P<0.01),脑组织cleaved caspase-3和Bax表达明显下调、Bcl-2表达明显上调(P<0.01),脑组织RhoA、Rho-kinaseα和Rho-kinaseβmRNA表达水平明显下调(P<0.01),给予Rho/Rho激酶信号通路激活剂水仙环素后,可逆转上述改变.结论:羟丁酸钠通过抑制Rho/Rho激酶信号通路减轻脑缺血再灌注大鼠脑损伤.
    • 胡珊; 彭军; 姜丹
    • 摘要: 目的 分析羟丁酸钠用于帕金森(Parkinson's disease,PD)睡眠障碍患者治疗的有效性.方法 选取2017年1月—2018年6月79例PD睡眠障碍者为研究对象,按治疗小组不同分组,对照组以普拉克索进行治疗(共39例)、观察组以普拉克索、羟丁酸钠治疗(共40例),观察两组睡眠质量情况,评估不同用药治疗效果差异.结果 入院时两组PSQI、PDSS评分组间比较差异无统计学意义(P>0.05),治疗后观察组PSQI评分低于对照组,PDSS评分高于对照组(P<0.05);观察组治疗率为95.00%,高于对照组79.49%(P<0.05).结论 羟丁酸钠用于PD睡眠障碍者治疗,能有效提高患者睡眠质量,临床治疗效果良好.
    • 黄潇; 齐家磊; 韩艳艳; 周宇; 蒋涛; 张励才
    • 摘要: 目的 探讨羟丁酸钠对缺血-再灌注(I-R)损伤小鼠小肠功能的影响.方法 将90只昆明种小鼠随机均分为三组:S组为假手术对照;其余两组采用肠系膜上动脉夹闭20 min、再灌注1h建立肠I-R损伤模型.I-R组为模型对照,I-R+SO组于肠I-R损伤前30 min腹腔注射羟丁酸钠50 mg/kg预处理.术后用亚甲蓝灌胃法检测小肠蠕动功能,木糖灌胃法检测小肠吸收功能,ELISA法检测小肠黏膜IL-6含量.结果 与I-R组相比,I-R+SO组亚甲蓝移动率升高(P<0.05),木糖吸收量和小肠黏膜中IL-6的含量降低(P<0.05).结论 羟丁酸钠对小鼠小肠I-R损伤有保护作用,且可下调IL-6的表达.
    • 于冬梅; 张倩; 周锦; 曹惠鹃; 张铁铮
    • 摘要: 目的:比较不同剂量羟丁酸钠对离体大鼠缺血再灌注损伤心肌脂质过氧化作用的影响。方法将24只成年Wistar大鼠随机分为4组(n=6):心肌缺血再灌注组(I/R组),1 mmol/L羟丁酸钠组(RL组),2.5 mmol/L羟丁酸钠组( RM组),10 mmol/L羟丁酸钠组( RH组)。采用 Langendorff离体心脏缺血再灌注模型,四组均以K-H液平衡灌注10 min,再以K-H液及1、2.5、10 mmol/L羟丁酸钠的K-H液分别灌注10 min,然后全心停止灌注25 min,再分别继续灌注30 min。测定冠脉流出液总乳酸脱氢酶( LDH)活性;灌注末,用2.5%戊二醛固定左室心肌组织,观察心肌超微结构;留取心尖部心肌组织以检测8-异前列腺素、超氧化物歧化酶(SOD)活性。结果与IR组比较,RL组8-异前列腺素含量、SOD及LDH活性差异均无统计学意义(P>0.05),超微结构也未见损伤减轻;RM组8-异前列腺素含量、SOD活性差异均无统计学意义(P>0.05),LDH活性差异有统计学意义(P0.05),超微结构可见损伤加重。结论羟丁酸钠(1、2.5 mmol/L)不能降低心肌缺血再灌注损伤大鼠的8-异前列腺素含量,抑制脂质过氧化反应;但是2.5 mmol/L羟丁酸钠能减轻大鼠心肌缺血再灌注损伤;10 mmol/L羟丁酸钠则加重了脂质过氧化反应和心肌缺血再灌注损伤。%Objective To compare the effects of three different doses of gamma-hydroxybutyrate on lipid per-oxidation in isolated rat hearts after myocardial ischemia-reperfusion. Methods Twenty-four adult Wistar rats were randomly divided into 4 groups ( 6 rats in each group ):ischemia-reperfusion group ( I/R group ) , I/R + gamma-hydroxybutyrate (1,2. 5,10 mmol/L) groups (RL,RM,RH groups). The isolated rat hearts were perfused with Lan-gendorff perfusion system. All the rat hearts were initially perfused with Krebs-Henseleit ( K-H) solution for 10 min, then respectively perfused with K-H solution dissolved no gamma-hydroxybutyrate,gamma-hydroxybutyrate (1,2. 5, 10 mmol/L) for 10 min followed by 25 min global ischemia and 30 min reperfusion. The total lactate dehydrogenase ( LDH) of the reperfusion solution,levels of 8-isoprostane and SOD activity of apex of hearts were determined. The left ventricular tissues were used for observing myocardial ultrastructure. Results The levels of 8-isoprostane, LDH and SOD activity in group RL did not significantly differ from I/R group ( P>0. 05 ) . The myocardial ultrastructure also showed that group RL cannot lessened the myocardial I/R injury. Although levels of 8-isoprostane and SOD activity in group RM did not significantly differ from those in I/R group (P>0. 05),the LDH activity differed significantly(P<0. 05). The microscopic examination indicated that group RM can alleviate the myocardial I/R injury,but compared with I/R group,levels of 8-isoprostane and LDH were raised significantly ( P <0. 05 ) , the myocardial ultrastructure was injuried more seriously. Conclusion Gamma-hydroxybutyrate (1,2. 5 mmol/L) cannot decrease the levels of 8-isoprostane or inhibit lipid peroxidation. But 2. 5 mmol/L Gamma-hydroxybutyrate can alleviate the myocardial I/R in-jury. While 10 mmol/L Gamma-hydroxybutyrate can exacerbated lipid peroxidation and myocardial ischemia-reperfu-sion injury.
    • 谢敏; 王硕; 马吉宁; 刘卫卫; 孙斌; 张咏梅
    • 摘要: Objective To investigate the effects of different dose of ketamine and sodium oxybate on gastrointestinal peristalsis in mice model of formalin-induced pain. Methods The mice were divided into three groups by Random number method and Stratified sampling: pain model group (n=32), intravenous anesthetic group (n=24), and pain model+intravenous anesthetic group(n=56). During the experiment, a meal consisting of an aqueous suspension(0.3 ml) of 12% charcoal, used as a marker, and 4% tragacanth mucilage was administered intragastrically. The percentage distance traveled by the charcoal plug in the small intestine (from the pylorus to the caecum) was measured as the gastrointestinal transit 30 min after receiving the test meal. The mice received an intra plantar injection of different concentration (2, 4, 6% ) of formalin solution as formalin induced pain model. Results (① The 2% dose of formalin significantly reduced the rate of gastrointestinal motility in mice [ (45±9)% vs (54±11 )%, P<0.05 ], while the 4% and 6% dose of formalin had little influence on gastrointestinal motility than that in black group. ② The intraperitoneal injection of anesthetic-doses of ketamine and sodium oxybate slowed down the gastrointestinal motility in mice, but had no statistical significance than that in normal saline group (P>0.05). ③ For formalin-induced pain model, compared with normal saline group the anesthetic-dose of ketamine increased the rate of gastrointestinal motility in mice [ (69±11)% vs (61±7)%, P<0.05 ]. Analgesic-dose and low-dose of ketamine[(59±7)% and (61±6)%]had little effect on gastrointestinal motility in mice(P>0.05). The anesthetic-dose and low-dose of sodium oxybate[ (48±5)% and (52±6)%] decreased the rate of gastrointestinal motility(P<0.05). Conclusion The 2% dose of formalin significantly reduced the rate of gastrointestinal motility in mice. The anesthesia-dose ketamine promoted the gastrointestinal motility in formalin-induced pain model mice, while the anesthetic-dose and low-dose of sodium oxybate could inhibit the gastrointestinal motility in mice.%目的探讨不同浓度氯胺酮、羟丁酸钠对福尔马林致痛小鼠胃肠推进运动的影响。方法实验小鼠按随机数字法分层随机,分为疼痛模型组(32只)、静脉麻醉药组(24只)、静脉麻醉药+疼痛模型组(56只)共3组。各组均采用炭末胶液(含12%活性炭和4%黄芪胶)灌胃,计算30 min炭末胶液在小肠内推进距离占小肠全长的百分比,以此作为胃肠推进运动的指标。小鼠足底皮下分别注射2%、4%、6%浓度福尔马林溶液建立福尔马林炎性疼痛模型。结果①与正常对照组相比,2%福尔马林疼痛模型组小鼠胃肠推进运动明显减慢[(45±9)%vs(54±ll)%,P<0.05],而4%及6%福尔马林疼痛模型组小鼠胃肠推进运动差异无统计学意义。②与生理盐水组相比,麻醉剂量氯胺酮和羟丁酸钠组小鼠胃肠推进运动虽有不同程度减慢,但差异无统计学意义(P>0.05)。③在4%福尔马林疼痛模型下,与生理盐水组相比,麻醉剂量氯胺酮组增加小鼠胃肠推进运动[(69±l1)%vs(61±7)%,P<0.05],镇痛剂量[(59±7)%]与小剂量氯胺酮组[(61±6)%]对胃肠推进运动影响甚微(P>0.05),麻醉剂量[(48±5)%]与小剂量羟丁酸钠组[(52±6)%]胃肠推进运动减慢(P<0.05)。结论2%福尔马林疼痛模型组小鼠胃肠推进运动明显减慢,腹腔注射麻醉剂量氯胺酮能促进疼痛刺激后小鼠的胃肠推进运动,而麻醉剂量和小剂量羟丁酸钠则抑制小鼠的胃肠推进。
  • 查看更多

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号